Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells.
Kiefer M, Thurner L, Bock T, Cetin O, Kos I, Lesan V, Kaddu-Mulindwa D, Bittenbring JT, Fadle N, Regitz E, Hoth M, Neumann F, Preuss KD, Pfreundschuh M, Christofyllakis K, Bewarder M.
Kiefer M, et al. Among authors: hoth m.
EJHaem. 2022 Dec 27;4(1):125-134. doi: 10.1002/jha2.635. eCollection 2023 Feb.
EJHaem. 2022.
PMID: 36819155
Free PMC article.